Credit Agricole
NAGE

Credit Agricole’s Niagen Bioscience NAGE Stock Holding History

Credit Agricole’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$415K Hold
130,000
– – ﹤0.01% 1241
2026
Q1 		$573K Buy
+130,000
New +$702K ﹤0.01% 1170

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Credit Agricole's NAGE Position: Q2 2026 in Review

Credit Agricole held its Niagen Bioscience (NAGE) position steady in Q2 2026 at 130,000 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #1241.

Credit Agricole first reported a position in NAGE in Q1 2026 and has held it in 2 quarters since. The position peaked at $573K in Q1 2026. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • Credit Agricole held 130,000 shares of Niagen Bioscience worth $415K as of Q2 2026.
  • Credit Agricole left its Niagen Bioscience share count unchanged in Q2 2026.
  • Niagen Bioscience made up ﹤0.01% of Credit Agricole's portfolio in Q2 2026, its #1241 holding.
  • Credit Agricole first reported a position in Niagen Bioscience in Q1 2026 and has held it in 2 quarters since.
  • Credit Agricole's Niagen Bioscience position peaked at $573K in Q1 2026.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.